ABVC BioPharma (ABVC) News Today $1.17 +0.05 (+4.46%) As of 12:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in TaiwanMay 1, 2025 | finance.yahoo.comUPDATE: ABVC BioPharma Announces 2024 Financial ResultsApril 18, 2025 | nasdaq.comEQS-News: UPDATE: ABVC BioPharma Announces 2024 Financial ResultsApril 16, 2025 | markets.businessinsider.comABVC BioPharma Announces 2024 Financial ResultsApril 15, 2025 | finance.yahoo.comEQS-News: ABVC BioPharma Announces 2024 Financial ResultsApril 15, 2025 | markets.businessinsider.comEQS-News: ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 MillionApril 3, 2025 | markets.businessinsider.comABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 MillionApril 3, 2025 | finance.yahoo.comABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth PotentialMarch 19, 2025 | finance.yahoo.comEQS-News: ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth PotentialMarch 19, 2025 | markets.businessinsider.comABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical NeedsMarch 5, 2025 | finance.yahoo.comEQS-News: ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical NeedsMarch 5, 2025 | markets.businessinsider.comABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global MarketsFebruary 26, 2025 | finance.yahoo.comABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025February 20, 2025 | finance.yahoo.comEQS-News: ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025February 20, 2025 | markets.businessinsider.comABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 16, 2025 | finance.yahoo.comEQS-News: ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 16, 2025 | markets.businessinsider.comNon-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsightJanuary 14, 2025 | finance.yahoo.comEQS-News: AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing FeesJanuary 14, 2025 | markets.businessinsider.comABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related ProductsJanuary 7, 2025 | finance.yahoo.comABVC BioPharma believes ABV-1504 can fill void in market after ProzacDecember 20, 2024 | markets.businessinsider.comABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21December 19, 2024 | markets.businessinsider.comABVC BioPharma receives $200,000 cash payment from OncoXDecember 12, 2024 | markets.businessinsider.comABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three PartnersDecember 11, 2024 | globenewswire.comABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational MilestonesNovember 14, 2024 | finance.yahoo.comRAKUS Co., Ltd. Reports Strong Growth in 2024November 14, 2024 | msn.comABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic PartnersOctober 22, 2024 | globenewswire.comABVC BioPharma (NASDAQ:ABVC) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic AchievementsAugust 15, 2024 | globenewswire.comABVC BioPharma's CEO Discusses New Drug Development and AI IntegrationJuly 19, 2024 | finance.yahoo.comImmunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Eligible to Receive Aggregate Income of $13.75M and Royalties of up to $12.50MMay 24, 2024 | finance.yahoo.comABVC CEO's Letter to Shareholders: The Future Looks Bright for ABVC; Anticipating Cash Incomes Totaling up to $24MMay 22, 2024 | finance.yahoo.comABVC Stock Earnings: ABVC BioPharma Reported Results for Q1 2024May 17, 2024 | investorplace.comPromising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13.75M and Royalties of up to $12.50MMay 15, 2024 | finance.yahoo.comCombination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50MMay 9, 2024 | finance.yahoo.comABVC BioPharma, Inc. (ABVC)April 26, 2024 | finance.yahoo.comABVC BioPharma inks licensing deal for cancer drugApril 18, 2024 | investing.comABVC BioPharma, Inc.: AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per ShareApril 18, 2024 | finanznachrichten.deAiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per ShareApril 18, 2024 | globenewswire.comABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404April 17, 2024 | markets.businessinsider.comABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50MApril 17, 2024 | finance.yahoo.comABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50MApril 17, 2024 | globenewswire.comABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50MApril 10, 2024 | globenewswire.comABVC BioPharma, Inc.: ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60MMarch 28, 2024 | finanznachrichten.deWhy ABVC BioPharma Stock Is Up TodayMarch 27, 2024 | msn.comABVC Announces Global Licensing Deal With ForSeeCon Eye For VitargusMarch 26, 2024 | markets.businessinsider.comABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60MMarch 26, 2024 | globenewswire.comAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million DollarsMarch 21, 2024 | finance.yahoo.comABVC BioPharma, Inc. (ABVC) Interactive Stock Chart - Yahoo FinanceMarch 19, 2024 | ca.finance.yahoo.comABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia MagazineMarch 19, 2024 | globenewswire.comABVC BioPharma, Inc.: ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business UpdateMarch 14, 2024 | finanznachrichten.de Get ABVC BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. Email Address ABVC Media Mentions By Week ABVC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABVC News Sentiment▼-0.470.69▲Average Medical News Sentiment ABVC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABVC Articles This Week▼20▲ABVC Articles Average Week Get ABVC BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clearside Biomedical News Today Cabaletta Bio News Today BeyondSpring News Today Pyxis Oncology News Today PyroGenesis Canada News Today Inozyme Pharma News Today Skye Bioscience News Today Alto Neuroscience News Today Ikena Oncology News Today Rani Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABVC) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABVC Stock Free ABVC Stock Alerts